Category: Scribes
-
Brazil Potash (GRO.NYSE) bets big on domestic supply as global potash politics simmer
Disclaimer: This article has been paid for by Brazil Potash. See disclosures at the bottom of the page. The world is in turmoil. Decades old trade deals are out the window. Agreements you could bank on, that you could set your retirement money to, risk being shattered into pieces on political whims. Love him or…
-
Emerita Resources (EMO.V) legal battle may be set to pay off this month
The offices of Emerita Resources (EMO.V) are abuzz right now, in that a decade long legal process to defend its perceived right to exploit the Aznalcóllar mine is finally coming to a head. If EMO wins the lawsuit, as is expected by many, the company will have the right to reopen a mine of significance…
-
Highballer Report: Gold’s big run and the juniors benefitting
March 17, 2025 —– Greg Nolan After a tumultuous week that rattled those with significant exposure to general equities, particularly tech, the precious metal, which initially took a hit during the extreme market volatility, snapped right back and went on to storm all-time highs. Again. But this time, the assault was on the loftiest of…
-
Prospera Energy (PEI.V) with no money to pay creditors, buys chairman Shubham Garg’s debt
In what can only be labeled as one of the most tone deaf and literally self serving deals of the year, Prospera Energy (PEI.V), which we’ve chronicled here plenty as a giant bad debt on wheels, has announced an ‘aquisition’ of White Tundra Petroelum, otherwise known as ‘the chairman’s problem.’ For the uninitiated, Prospera owes..…
-
Prospera Energy (PEI.V)’s big corporate evolution: From incompetence to dishonesty
Every junior markets public company goes through an evolution or five in the first few years of their life. It’s natural. Any time you’re expected to get from ‘adventurous idea’ to profit quickly, with a daily scorecard on your back and short sellers and day traders and brokers rummaging through your pockets any tme you…
-
Brera Holdings (BREA.Q) pioneering pubco sports investment model, but is it a win?
Let’s open this piece with a quick aside acknowledging that I pitched my services to Brera Holdings (BREA.Q) recently, and though we talked a lot and came close to a deal, they ultimately haven’t decided to use me for market awareness. That’s just a disclosure, not a warning – I’m writing about them today regardless…
-
“The markets are dead!”: Emerita Resources (EMO.V) shows otherwise with massive upside coming
On a long enough timeline, all public company news moves from good to bad, important to unimportant, and vice versa. A couple of years ago, the news that Emerita Resources’ (EMO.V) court case in Spain would happen in March 2025 saw shareholders hitting the sell button en masse. Yes, it looked likely the $25 billion…
-
Lithium Ionic (LTH.V) is up 50% in 3 months, and is moving toward production
On August 30 this summer, we posted a story about a resource explorer called Lithium Ionic (LTH.V), in which we said: Lithium Ionic isn’t out there asking investors to help them finance a drill hole in the hope they’ll find something. They found something. They’ve got something. We then made the case for LTH being a…
-
Digital Twinning, and how EdgeTI (CTRL.V) is a serious story you’ve never heard of
I first heard the term ‘digital twin’ in 2019, in connection with a high performance computing company I was associated with that was running a project for Boeing. The aerospace giant, at the time, was considering building a filthy fat production line that would dwarf all that came before it, but didn’t want to spend…
-
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
As the world increasingly faces the complexities of autoimmune and neurodegenerative diseases, new medical advancements are crucial to better serve patients’ needs. Enter Bionxt Solutions Inc. (BNXT.C), a bioscience innovator making moves with its groundbreaking sublingual (under-the-tongue) drug delivery technology. This technology, now in the process of securing national-level patents globally, represents a shift from…
